UniProt ID | FMNL3_HUMAN | |
---|---|---|
UniProt AC | Q8IVF7 | |
Protein Name | Formin-like protein 3 | |
Gene Name | FMNL3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1028 | |
Subcellular Localization |
Cytoplasm . Cell membrane Lipid-anchor . Enriched in lamellipodia. |
|
Protein Description | Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Required for developmental angiogenesis (By similarity). In this process, required for microtubule reorganization and for efficient endothelial cell elongation. In quiescent endothelial cells, triggers rearrangement of the actin cytoskeleton, but does not alter microtubule alignement.. | |
Protein Sequence | MGNLESAEGVPGEPPSVPLLLPPGKMPMPEPCELEERFALVLSSMNLPPDKARLLRQYDNEKKWDLICDQERFQVKNPPHTYIQKLQSFLDPSVTRKKFRRRVQESTKVLRELEISLRTNHIGWVREFLNDENKGLDVLVDYLSFAQCSVMFDFEGLESGDDGAFDKLRSWSRSIEDLQPPSALSAPFTNSLARSARQSVLRYSTLPGRRALKNSRLVSQKDDVHVCILCLRAIMNYQYGFNLVMSHPHAVNEIALSLNNKNPRTKALVLELLAAVCLVRGGHEIILAAFDNFKEVCKELHRFEKLMEYFRNEDSNIDFMVACMQFINIVVHSVEDMNFRVHLQYEFTKLGLEEFLQKSRHTESEKLQVQIQAYLDNVFDVGGLLEDAETKNVALEKVEELEEHVSHLTEKLLDLENENMMRVAELEKQLLQREKELESIKETYENTSHQVHTLRRLIKEKEEAFQRRCHLEPNVRGLESVDSEALARVGPAELSEGMPPSDLDLLAPAPPPEEVLPLPPPPAPPLPPPPPPLPDKCPPAPPLPGAAPSVVLTVGLSAIRIKKPIKTKFRLPVFNWTALKPNQISGTVFSELDDEKILEDLDLDKFEELFKTKAQGPALDLICSKNKTAQKAASKVTLLEANRAKNLAITLRKAGRSAEEICRAIHTFDLQTLPVDFVECLMRFLPTEAEVKLLRQYERERQPLEELAAEDRFMLLFSKVERLTQRMAGMAFLGNFQDNLQMLTPQLNAIIAASASVKSSQKLKQMLEIILALGNYMNSSKRGAVYGFKLQSLDLLLDTKSTDRKMTLLHFIALTVKEKYPDLANFWHELHFVEKAAAVSLENVLLDVKELGRGMELIRRECSIHDNSVLRNFLSTNEGKLDKLQRDAKTAEEAYNAVVRYFGESPKTTPPSVFFPVFVRFIRSYKEAEQENEARKKQEEVMREKQLAQEAKKLDAKTPSQRNKWQQQELIAELRRRQAKEHRPVYEGKDGTIEDIITVLKSVPFTARTAKRGSRFFCDAAHHDESNC | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | N-myristoyl glycine | ------MGNLESAEG ------CCCCCCCCC | 59.75 | - | |
2 | Myristoylation | ------MGNLESAEG ------CCCCCCCCC | 59.75 | 20213681 | |
6 | Phosphorylation | --MGNLESAEGVPGE --CCCCCCCCCCCCC | 34.48 | 24850871 | |
16 | Phosphorylation | GVPGEPPSVPLLLPP CCCCCCCCCCEECCC | 47.27 | 24850871 | |
58 | Phosphorylation | KARLLRQYDNEKKWD HHHHHHHHCCCCCCE | 17.82 | 20068231 | |
88 | Phosphorylation | TYIQKLQSFLDPSVT HHHHHHHHHCCHHHC | 37.91 | 21406692 | |
93 | Phosphorylation | LQSFLDPSVTRKKFR HHHHCCHHHCHHHHH | 35.47 | 30266825 | |
93 (in isoform 3) | Phosphorylation | - | 35.47 | 27251275 | |
95 | Phosphorylation | SFLDPSVTRKKFRRR HHCCHHHCHHHHHHH | 40.90 | 30266825 | |
170 | Phosphorylation | GAFDKLRSWSRSIED CHHHHHHHHHHCHHH | 39.58 | 29514088 | |
172 | Phosphorylation | FDKLRSWSRSIEDLQ HHHHHHHHHCHHHCC | 19.86 | 29514088 | |
174 | Phosphorylation | KLRSWSRSIEDLQPP HHHHHHHCHHHCCCC | 25.47 | 30266825 | |
174 (in isoform 3) | Phosphorylation | - | 25.47 | 24719451 | |
182 | Phosphorylation | IEDLQPPSALSAPFT HHHCCCCCHHCCCCC | 48.83 | 30266825 | |
185 | Phosphorylation | LQPPSALSAPFTNSL CCCCCHHCCCCCHHH | 33.34 | 29255136 | |
189 (in isoform 3) | Phosphorylation | - | 23.88 | 27251275 | |
189 | Phosphorylation | SALSAPFTNSLARSA CHHCCCCCHHHHHHH | 23.88 | 29255136 | |
191 | Phosphorylation | LSAPFTNSLARSARQ HCCCCCHHHHHHHHH | 21.98 | 29255136 | |
199 | Phosphorylation | LARSARQSVLRYSTL HHHHHHHHHHHHCCC | 19.98 | 28348404 | |
199 (in isoform 3) | Phosphorylation | - | 19.98 | 27251275 | |
203 | Phosphorylation | ARQSVLRYSTLPGRR HHHHHHHHCCCCCHH | 11.22 | 26657352 | |
204 | Phosphorylation | RQSVLRYSTLPGRRA HHHHHHHCCCCCHHH | 19.62 | 26657352 | |
205 | Phosphorylation | QSVLRYSTLPGRRAL HHHHHHCCCCCHHHH | 28.21 | 23403867 | |
255 | Ubiquitination | PHAVNEIALSLNNKN HHHHHHHHHHCCCCC | 5.73 | 23000965 | |
307 | Ubiquitination | LHRFEKLMEYFRNED HHHHHHHHHHHHCCC | 6.09 | 23000965 | |
326 | Ubiquitination | FMVACMQFINIVVHS HHHHHHHHHHHHEEC | 1.51 | 23000965 | |
330 | Ubiquitination | CMQFINIVVHSVEDM HHHHHHHHEECHHHC | 2.47 | 23000965 | |
333 | Ubiquitination | FINIVVHSVEDMNFR HHHHHEECHHHCCCE | 18.65 | 23000965 | |
358 | Ubiquitination | GLEEFLQKSRHTESE CHHHHHHHCCCCCCH | 52.16 | 23000965 | |
377 | Ubiquitination | QIQAYLDNVFDVGGL HHHHHHCCCCCCCCH | 33.49 | 23000965 | |
443 | Phosphorylation | ELESIKETYENTSHQ HHHHHHHHHHCCHHH | 31.00 | 23663014 | |
444 | Phosphorylation | LESIKETYENTSHQV HHHHHHHHHCCHHHH | 14.31 | 23663014 | |
447 | Phosphorylation | IKETYENTSHQVHTL HHHHHHCCHHHHHHH | 18.69 | 23663014 | |
448 | Phosphorylation | KETYENTSHQVHTLR HHHHHCCHHHHHHHH | 24.41 | 23663014 | |
453 (in isoform 3) | Phosphorylation | - | 24.09 | 27251275 | |
453 | Phosphorylation | NTSHQVHTLRRLIKE CCHHHHHHHHHHHHH | 24.09 | 23663014 | |
480 | Phosphorylation | PNVRGLESVDSEALA CCCCCCCCCCHHHHH | 35.95 | 27470641 | |
624 | Phosphorylation | PALDLICSKNKTAQK CHHHHHCCCCHHHHH | 32.06 | 27251275 | |
624 (in isoform 3) | Phosphorylation | - | 32.06 | 27251275 | |
628 | O-linked_Glycosylation | LICSKNKTAQKAASK HHCCCCHHHHHHHHH | 43.65 | 30379171 | |
645 | Ubiquitination | LLEANRAKNLAITLR HHHHHHHHHHHHHHH | 49.62 | - | |
672 | Phosphorylation | IHTFDLQTLPVDFVE HHHCCCCCCCCCHHH | 40.08 | - | |
687 | Phosphorylation | CLMRFLPTEAEVKLL HHHHHCCCHHHHHHH | 50.39 | - | |
697 | Phosphorylation | EVKLLRQYERERQPL HHHHHHHHHHHCCCH | 15.54 | - | |
718 | Phosphorylation | DRFMLLFSKVERLTQ HHHHHHHHHHHHHHH | 35.44 | 24719451 | |
776 | Phosphorylation | IILALGNYMNSSKRG HHHHHHHHHCCCCCC | 8.89 | - | |
779 | Phosphorylation | ALGNYMNSSKRGAVY HHHHHHCCCCCCCCC | 22.24 | - | |
780 | Phosphorylation | LGNYMNSSKRGAVYG HHHHHCCCCCCCCCE | 22.74 | - | |
786 | Phosphorylation | SSKRGAVYGFKLQSL CCCCCCCCEEEHHHC | 19.13 | - | |
799 | Phosphorylation | SLDLLLDTKSTDRKM HCCEEECCCCCCCHH | 27.19 | - | |
807 | Phosphorylation | KSTDRKMTLLHFIAL CCCCCHHHHHHHHHH | 29.24 | 27499020 | |
815 | Phosphorylation | LLHFIALTVKEKYPD HHHHHHHHHHHHCCC | 22.10 | 27499020 | |
958 | Phosphorylation | AKKLDAKTPSQRNKW HHHCCCCCHHHCCHH | 29.87 | 23403867 | |
960 | Phosphorylation | KLDAKTPSQRNKWQQ HCCCCCHHHCCHHHH | 47.18 | 24719451 | |
992 | Phosphorylation | VYEGKDGTIEDIITV CCCCCCCCHHHHHHH | 31.18 | 29514088 | |
1002 | O-linked_Glycosylation | DIITVLKSVPFTART HHHHHHHHCCCCHHC | 30.75 | 30379171 | |
1009 | O-linked_Glycosylation | SVPFTARTAKRGSRF HCCCCHHCCCCCCCE | 33.78 | 30379171 | |
1014 | Phosphorylation | ARTAKRGSRFFCDAA HHCCCCCCCEECCCC | 29.92 | 27422710 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FMNL3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FMNL3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FMNL3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Myristoylation | |
Reference | PubMed |
"Strategy for comprehensive identification of human N-myristoylatedproteins using an insect cell-free protein synthesis system."; Suzuki T., Moriya K., Nagatoshi K., Ota Y., Ezure T., Ando E.,Tsunasawa S., Utsumi T.; Proteomics 10:1780-1793(2010). Cited for: MYRISTOYLATION AT GLY-2. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174, AND MASSSPECTROMETRY. |